{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:00:32Z","timestamp":1761490832066,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Natural Science Foundations of China","award":["Grant No.81273361"],"award-info":[{"award-number":["Grant No.81273361"]}]},{"name":"the Natural Science Foundation of Tianjin","award":["Grant No.16JCZDJC32500"],"award-info":[{"award-number":["Grant No.16JCZDJC32500"]}]},{"name":"the International (Regional) Cooperation and Exchange Project of the National Natural Science Foundation of China","award":["Grant No.81611130090"],"award-info":[{"award-number":["Grant No.81611130090"]}]},{"name":"The Science&Technology Development Fund of Tianjin Education Commission for Higher Education","award":["Grant No.2017KJ229"],"award-info":[{"award-number":["Grant No.2017KJ229"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10822-019-00213-z","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T07:02:41Z","timestamp":1562914961000},"page":"759-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Structure based design of selective SHP2 inhibitors by De novo design, synthesis and biological evaluation"],"prefix":"10.1007","volume":"33","author":[{"given":"Wen-Shan","family":"Liu","sequence":"first","affiliation":[]},{"given":"Wen-Yan","family":"Jin","sequence":"additional","affiliation":[]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Xing-Hua","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Wei-Ya","family":"Li","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-6483","authenticated-orcid":false,"given":"Ying","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Run-Ling","family":"Wang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"issue":"4","key":"213_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","volume":"92","author":"P Hof","year":"1998","unstructured":"Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE (1998) Crystal structure of the tyrosine phosphatase SHP-2. Cell 92(4):441\u2013450","journal-title":"Cell"},{"key":"213_CR2","doi-asserted-by":"publisher","first-page":"17626","DOI":"10.1038\/srep17626","volume":"5","author":"C Chen","year":"2015","unstructured":"Chen C, Cao M, Zhu S, Wang C, Liang F, Yan L, Luo D (2015) Discovery of a novel inhibitor of the protein tyrosine phosphatase Shp2. Sci Rep 5:17626. \n                    https:\/\/doi.org\/10.1038\/srep17626","journal-title":"Sci Rep"},{"issue":"6","key":"213_CR3","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1021\/jm901645u","volume":"53","author":"X Zhang","year":"2010","unstructured":"Zhang X, He Y, Liu S, Yu Z, Jiang ZX, Yang Z, Dong Y, Nabinger SC, Wu L, Gunawan AM, Wang L, Chan RJ, Zhang ZY (2010) Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). J Med Chem 53(6):2482\u20132493. \n                    https:\/\/doi.org\/10.1021\/jm901645u","journal-title":"J Med Chem"},{"issue":"7459","key":"213_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature12396","volume":"499","author":"W Yang","year":"2013","unstructured":"Yang W, Wang J, Moore DC, Liang H, Dooner M, Wu Q, Terek R, Chen Q, Ehrlich MG, Quesenberry PJ, Neel BG (2013) Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature 499(7459):491\u2013495. \n                    https:\/\/doi.org\/10.1038\/nature12396","journal-title":"Nature"},{"issue":"16","key":"213_CR5","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1021\/jm8002526","volume":"51","author":"HR Lawrence","year":"2008","unstructured":"Lawrence HR, Pireddu R, Chen L, Luo Y, Sung SS, Szymanski AM, Yip ML, Guida WC, Sebti SM, Wu J, Lawrence NJ (2008) Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds. J Med Chem 51(16):4948\u20134956. \n                    https:\/\/doi.org\/10.1021\/jm8002526","journal-title":"J Med Chem"},{"issue":"3","key":"213_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/blood-2006-07-028829","volume":"109","author":"RJ Chan","year":"2007","unstructured":"Chan RJ, Feng GS (2007) PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase. Blood 109(3):862\u2013867. \n                    https:\/\/doi.org\/10.1182\/blood-2006-07-028829","journal-title":"Blood"},{"issue":"24","key":"213_CR7","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","volume":"64","author":"M Bentires-Alj","year":"2004","unstructured":"Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG (2004) Activating mutations of the noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 64(24):8816\u20138820. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1923","journal-title":"Cancer Res"},{"issue":"2","key":"213_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1124\/mol.106.025536","volume":"70","author":"L Chen","year":"2006","unstructured":"Chen L, Sung SS, Yip ML, Lawrence HR, Ren Y, Guida WC, Sebti SM, Lawrence NJ, Wu J (2006) Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol Pharmacol 70(2):562\u2013570. \n                    https:\/\/doi.org\/10.1124\/mol.106.025536","journal-title":"Mol Pharmacol"},{"issue":"7","key":"213_CR9","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1021\/acsmedchemlett.5b00118","volume":"6","author":"R He","year":"2015","unstructured":"He R, Yu ZH, Zhang RY, Wu L, Gunawan AM, Lane BS, Shim JS, Zeng LF, He Y, Chen L, Wells CD, Liu JO, Zhang ZY (2015) Exploring the existing drug space for novel pTyr mimetic and SHP2 inhibitors. ACS Med Chem Lett 6(7):782\u2013786. \n                    https:\/\/doi.org\/10.1021\/acsmedchemlett.5b00118","journal-title":"ACS Med Chem Lett"},{"issue":"17","key":"213_CR10","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1021\/acs.jmedchem.6b00680","volume":"59","author":"JG Fortanet","year":"2016","unstructured":"Fortanet JG, Chen CHT, Chen YNP, Chen ZL, Deng Z, Firestone B, Fekkes P, Fodor M, Fortin PD, Fridrich C, Grunenfelder D, Ho S, Kang ZB, Karki R, Kato M, Keen N, LaBonte LR, Larrow J, Lenoir F, Liu G, Liu SM, Lombardo F, Majumdar D, Meyer MJ, Palermo M, Perez L, Pu MY, Ramsey T, Sellers WR, Shultz MD, Stams T, Towler C, Wang P, Williams SL, Zhang JH, LaMarche MJ (2016) Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor. J Med Chem 59(17):7773\u20137782. \n                    https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00680","journal-title":"J Med Chem"},{"key":"213_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejphar.2016.12.012","volume":"795","author":"C Chen","year":"2017","unstructured":"Chen C, Liang F, Chen B, Sun Z, Xue T, Yang R, Luo D (2017) Identification of demethylincisterol A3 as a selective inhibitor of protein tyrosine phosphatase Shp2. Eur J Pharmacol 795:124\u2013133. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2016.12.012","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"213_CR12","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.4155\/Fmc.10.241","volume":"2","author":"AJ Barr","year":"2010","unstructured":"Barr AJ (2010) Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development. Future Med Chem 2(10):1563\u20131576. \n                    https:\/\/doi.org\/10.4155\/Fmc.10.241","journal-title":"Future Med Chem"},{"issue":"7610","key":"213_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nature18621","volume":"535","author":"YN Chen","year":"2016","unstructured":"Chen YN, LaMarche MJ, Chan HM, Fekkes P, Garcia-Fortanet J, Acker MG, Antonakos B, Chen CH, Chen Z, Cooke VG, Dobson JR, Deng Z, Fei F, Firestone B, Fodor M, Fridrich C, Gao H, Grunenfelder D, Hao HX, Jacob J, Ho S, Hsiao K, Kang ZB, Karki R, Kato M, Larrow J, La Bonte LR, Lenoir F, Liu G, Liu S, Majumdar D, Meyer MJ, Palermo M, Perez L, Pu M, Price E, Quinn C, Shakya S, Shultz MD, Slisz J, Venkatesan K, Wang P, Warmuth M, Williams S, Yang G, Yuan J, Zhang JH, Zhu P, Ramsey T, Keen NJ, Sellers WR, Stams T, Fortin PD (2016) Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature 535(7610):148\u2013152. \n                    https:\/\/doi.org\/10.1038\/nature18621","journal-title":"Nature"},{"issue":"1","key":"213_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1568005033342145","volume":"3","author":"AV Veselovsky","year":"2003","unstructured":"Veselovsky AV, Ivanov AS (2003) Strategy of computer-aided drug design. Curr Drug Targets Infect Disord 3(1):33\u201340","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"8","key":"213_CR15","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/jcb.23125","volume":"112","author":"W Wang","year":"2011","unstructured":"Wang W, Liu LJ, Song X, Mo Y, Komma C, Bellamy HD, Zhao ZJ, Zhou GW (2011) Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation. J Cell Biochem 112(8):2062\u20132071. \n                    https:\/\/doi.org\/10.1002\/jcb.23125","journal-title":"J Cell Biochem"},{"issue":"24","key":"213_CR16","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1093\/bioinformatics\/btw547","volume":"32","author":"A Prlic","year":"2016","unstructured":"Prlic A, Kalro T, Bhattacharya R, Christie C, Burley SK, Rose PW (2016) Integrating genomic information with protein sequence and 3D atomic level structure at the RCSB protein data bank. Bioinformatics 32(24):3833\u20133835. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btw547","journal-title":"Bioinformatics"},{"issue":"6","key":"213_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/cbdd.12283","volume":"83","author":"Y Ma","year":"2014","unstructured":"Ma Y, Jin YY, Wang YL, Wang RL, Lu XH, Kong DX, Xu WR (2014) The discovery of a novel and selective inhibitor of PTP1B over TCPTP: 3D QSAR pharmacophore modeling, virtual screening, synthesis, and biological evaluation. Chem Biol Drug Des 83(6):697\u2013709. \n                    https:\/\/doi.org\/10.1111\/cbdd.12283","journal-title":"Chem Biol Drug Des"},{"issue":"8","key":"213_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10822-009-9287-y","volume":"23","author":"CR Schubert","year":"2009","unstructured":"Schubert CR, Stultz CM (2009) The multi-copy simultaneous search methodology: a fundamental tool for structure-based drug design. J Comput Aided Mol Des 23(8):475\u2013489. \n                    https:\/\/doi.org\/10.1007\/s10822-009-9287-y","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"213_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00124387","volume":"6","author":"HJ Bohm","year":"1992","unstructured":"Bohm HJ (1992) The computer program LUDI: a new method for the De novo design of enzyme inhibitors. J Comput Aided Mol Des 6(1):61\u201378","journal-title":"J Comput Aided Mol Des"},{"issue":"8","key":"213_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrd1799","volume":"4","author":"G Schneider","year":"2005","unstructured":"Schneider G, Fechner U (2005) Computer-based De novo design of drug-like molecules. Nat Rev Drug Discov 4(8):649\u2013663. \n                    https:\/\/doi.org\/10.1038\/nrd1799","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"213_CR21","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM, Baldwin JJ (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43(21):3867\u20133877. \n                    https:\/\/doi.org\/10.1021\/jm000292e","journal-title":"J Med Chem"},{"issue":"4","key":"213_CR22","first-page":"540","volume":"5","author":"WJ Egan","year":"2002","unstructured":"Egan WJ, Walters WP, Murcko MA (2002) Guiding molecules towards drug-likeness. Curr Opin Drug Discov Dev 5(4):540\u2013549","journal-title":"Curr Opin Drug Discov Dev"},{"issue":"17","key":"213_CR23","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1021\/jm020266b","volume":"46","author":"A Cheng","year":"2003","unstructured":"Cheng A, Merz KM Jr (2003) Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships. J Med Chem 46(17):3572\u20133580. \n                    https:\/\/doi.org\/10.1021\/jm020266b","journal-title":"J Med Chem"},{"issue":"2","key":"213_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/pro.5560010204","volume":"1","author":"L Wesson","year":"1992","unstructured":"Wesson L, Eisenberg D (1992) Atomic solvation parameters applied to molecular dynamics of proteins in solution. Protein Sci 1(2):227\u2013235. \n                    https:\/\/doi.org\/10.1002\/pro.5560010204","journal-title":"Protein Sci"},{"issue":"18","key":"213_CR25","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1021\/jm0303195","volume":"47","author":"XY Xia","year":"2004","unstructured":"Xia XY, Maliski EG, Gallant P, Rogers D (2004) Classification of kinase inhibitors using a Bayesian model. J Med Chem 47(18):4463\u20134470. \n                    https:\/\/doi.org\/10.1021\/jm0303195","journal-title":"J Med Chem"},{"issue":"10","key":"213_CR26","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1021\/ci800081s","volume":"48","author":"J Koska","year":"2008","unstructured":"Koska J, Spassov VZ, Maynard AJ, Yan L, Austin N, Flook PK, Venkatachalam CM (2008) Fully automated molecular mechanics based induced fit protein-ligand docking method. J Chem Inf Model 48(10):1965\u20131973. \n                    https:\/\/doi.org\/10.1021\/ci800081s","journal-title":"J Chem Inf Model"},{"issue":"3","key":"213_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1110\/ps.062447107","volume":"16","author":"VZ Spassov","year":"2007","unstructured":"Spassov VZ, Yan L, Flook PK (2007) The dominant role of side-chain backbone interactions in structural realization of amino acid code. ChiRotor: a side-chain prediction algorithm based on side-chain backbone interactions. Protein Sci 16(3):494\u2013506. \n                    https:\/\/doi.org\/10.1110\/ps.062447107","journal-title":"Protein Sci"},{"issue":"13","key":"213_CR28","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/jcc.10306","volume":"24","author":"G Wu","year":"2003","unstructured":"Wu G, Robertson DH, Brooks CL 3rd, Vieth M (2003) Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem 24(13):1549\u20131562. \n                    https:\/\/doi.org\/10.1002\/jcc.10306","journal-title":"J Comput Chem"},{"issue":"2","key":"213_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/cbdd.12825","volume":"89","author":"A Abdolmaleki","year":"2017","unstructured":"Abdolmaleki A, Ghasemi F, Ghasemi JB (2017) Computer-aided drug design to explore cyclodextrin therapeutics and biomedical applications. Chem Biol Drug Des 89(2):257\u2013268. \n                    https:\/\/doi.org\/10.1111\/cbdd.12825","journal-title":"Chem Biol Drug Des"},{"issue":"5","key":"213_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.carres.2009.12.018","volume":"345","author":"CL Fernandes","year":"2010","unstructured":"Fernandes CL, Sachett LG, Pol-Fachin L, Verli H (2010) GROMOS96 43a1 performance in predicting oligosaccharide conformational ensembles within glycoproteins. Carbohydr Res 345(5):663\u2013671. \n                    https:\/\/doi.org\/10.1016\/j.carres.2009.12.018","journal-title":"Carbohydr Res"},{"key":"213_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jmgm.2014.08.005","volume":"54","author":"LL Zang","year":"2014","unstructured":"Zang LL, Wang XJ, Li XB, Wang SQ, Xu WR, Xie XB, Cheng XC, Ma H, Wang RL (2014) SAHA-based novel HDAC inhibitor design by core hopping method. J Mol Gr Model 54:10\u201318. \n                    https:\/\/doi.org\/10.1016\/j.jmgm.2014.08.005","journal-title":"J Mol Gr Model"},{"issue":"1","key":"213_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1021\/ct700200b","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess B (2008) P-LINCS: a parallel linear constraint solver for molecular simulation. J Chem Theory Comput 4(1):116\u2013122. \n                    https:\/\/doi.org\/10.1021\/ct700200b","journal-title":"J Chem Theory Comput"},{"issue":"7","key":"213_CR33","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari R, Kumar R, Lynn A, Consort OSDD (2014) g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54(7):1951\u20131962. \n                    https:\/\/doi.org\/10.1021\/ci500020m","journal-title":"J Chem Inf Model"},{"issue":"5","key":"213_CR34","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jcc.21666","volume":"32","author":"TJ Hou","year":"2011","unstructured":"Hou TJ, Wang JM, Li YY, Wang W (2011) Assessing the performance of the molecular mechanics\/Poisson Boltzmann surface area and molecular mechanics\/generalized born surface area methods. II. The accuracy of ranking poses generated from docking. J Comput Chem 32(5):866\u2013877. \n                    https:\/\/doi.org\/10.1002\/jcc.21666","journal-title":"J Comput Chem"},{"issue":"2","key":"213_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(Sici)1096-987x(19990130)20:2<217::Aid-Jcc4>3.0.Co;2-A","volume":"20","author":"J Weiser","year":"1999","unstructured":"Weiser J, Shenkin PS, Still WC (1999) Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem 20(2):217\u2013230. \n                    https:\/\/doi.org\/10.1002\/(Sici)1096-987x(19990130)20:2%3c217:Aid-Jcc4%3e3.0.Co;2-A","journal-title":"J Comput Chem"},{"issue":"2","key":"213_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins Struct Funct Bioinform 55(2):383\u2013394. \n                    https:\/\/doi.org\/10.1002\/prot.20033","journal-title":"Proteins Struct Funct Bioinform"},{"issue":"1","key":"213_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/Protein\/14.1.1","volume":"14","author":"F Tama","year":"2001","unstructured":"Tama F, Sanejouand YH (2001) Conformational change of proteins arising from normal mode calculations. Protein Eng 14(1):1\u20136. \n                    https:\/\/doi.org\/10.1093\/Protein\/14.1.1","journal-title":"Protein Eng"},{"issue":"28","key":"213_CR38","doi-asserted-by":"publisher","first-page":"17193","DOI":"10.1039\/c6ra27740c","volume":"7","author":"BW Tang","year":"2017","unstructured":"Tang BW, Li BQ, Qian YQ, Ao MT, Guo KQ, Fang MJ, Wu Z (2017) The molecular mechanism of hPPAR alpha activation. RSC Adv 7(28):17193\u201317201. \n                    https:\/\/doi.org\/10.1039\/c6ra27740c","journal-title":"RSC Adv"},{"issue":"11","key":"213_CR39","doi-asserted-by":"publisher","first-page":"e112419","DOI":"10.1371\/journal.pone.0112419","volume":"9","author":"K Kasahara","year":"2014","unstructured":"Kasahara K, Fukuda I, Nakamura H (2014) A novel approach of dynamic cross correlation analysis on molecular dynamics simulations and its application to Ets1 dimer-DNA complex. PLoS ONE 9(11):e112419. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0112419","journal-title":"PLoS ONE"},{"issue":"3","key":"213_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/prot.20497","volume":"60","author":"JC Cole","year":"2005","unstructured":"Cole JC, Murray CW, Nissink JWM, Taylor RD, Taylor R (2005) Comparing protein-ligand docking programs is difficult. Proteins Struct Funct Bioinform 60(3):325\u2013332. \n                    https:\/\/doi.org\/10.1002\/prot.20497","journal-title":"Proteins Struct Funct Bioinform"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-019-00213-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-019-00213-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-019-00213-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T23:26:12Z","timestamp":1594423572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-019-00213-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1007\/s10822-019-00213-z","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}